Your session is about to expire
← Back to Search
Procedure
Disposable Flexible Ureteroscope and Flexible Digital Ureteroscope for Kidney Stones
N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a single-use flexible ureteroscope for patients needing urinary tract examination. It aims to reduce costs and infection risks associated with reusable devices by using a disposable one. LithoVue was the first widely adopted single-use flexible ureteroscope.
Eligible Conditions
- Kidney Stones
- Urinary Tract Infection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Scope performance
Secondary study objectives
Operating room outcomes
Post-operative outcomes
Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: color interference
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Storz Flex-XC1 disposable flexible ureteroscopeExperimental Treatment1 Intervention
A patient is randomized to the experimental arm using the Storz Flex-XC1 disposable flexible ureteroscope.
Group II: Digital ureteroscopeExperimental Treatment1 Intervention
A patient is randomized to the experimental arm using a Digital ureteroscope.
Group III: Analogue scopeActive Control1 Intervention
A patient is not randomized to the experimental arm using the Storz Flex-XC1 disposable flexible ureteroscope.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Storz Flex-XC1 Disposable Flexible Ureteroscope
2022
N/A
~10
Storz Flexible Digital Ureteroscope
2022
N/A
~10
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,649 Previous Clinical Trials
958,765 Total Patients Enrolled
5 Trials studying Kidney Stones
604 Patients Enrolled for Kidney Stones
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.Men and women between the ages of 18 and 89 who need laser treatment of kidney stones via ureteroscopy.
Research Study Groups:
This trial has the following groups:- Group 1: Analogue scope
- Group 2: Storz Flex-XC1 disposable flexible ureteroscope
- Group 3: Digital ureteroscope
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.